Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
421.00    -3.00 (-0.71%)
Bid:
420.00
Ask:
424.50
Spread: 4.50 (1.071%)
Market Cap: £207.06m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Interim Management Statement

3 Nov 2008 07:00

RNS Number : 1755H
Zotefoams PLC
03 November 2008
 



3 November 2008

Zotefoams plc

("Zotefoams" or "the Company")

Interim Management Statement for the Quarter Ended 30 September 2008

Zotefoams, which manufactures and sells high-performance foams, announces its Interim Management Statement for the quarter ended 30 September 2008. 

In the first nine months of the year the Company has traded well and the Board remains confident of the Company's prospects although we have more limited visibility on our forward order book than in the recent past due to the current uncertain economic conditions.

In the third quarter sales have been in line with expectations and 10% higher than in the comparable period in 2007 including benefit from the weakness of Sterling against the Euro and US Dollar. As stated at the time of our Interim Results, the price of LDPE, our major raw material, has been rising throughout 2008 and Sterling prices paid in the third quarter were approximately 33% above those in the comparable period in 2007.  As there is a delay between purchasing and using raw materials, the major effect of these price increases will be felt in the fourth quarter, coinciding with our own price increase program.

Looking to the future and underpinned by the Board's confidence in the Company's prospects, we have increased resources in sales, marketing and product development during 2008.  We believe that this approach is essential for the development of our business in the medium term. 

 

The Company's balance sheet remains strong with net debt as at 30 September 2008 of £2.1 million, which equates to gearing of 8%, after the $3 million investment to purchase our associate share of MuCell Extrusion LLC during the third quarter and payment of our interim dividend of 1.5p per share in September.

Enquiries: 

Zotefoams plc 

0208-664-1600

David Stirling, Managing Director

Clifford Hurst, Finance Director 

Financial Dynamics Limited 

0207-269-7279

Ben Brewerton 

About Zotefoams plc 

Zotefoams plc (LSE - ZTF) is the world's leading producer of light weight, cross-linked, closed-cell block foams. These pure, consistent foams are manufactured using a unique environmentally friendly nitrogen expansion technology. Zotefoams was the first to develop cross-linked polyolefin foams and is increasingly using its production technology to manufacture foamed materials based on high-performance polymers. Based in CroydonUK, Zotefoams also manufactures in KentuckyUSA and markets its products worldwide through a global sales network. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUASORWORROAA
Date   Source Headline
8th Jun 202611:16 amRNSHolding(s) in Company
27th May 20264:06 pmRNSNotification of Transactions of Directors/PDMRs
27th May 20264:00 pmRNSResult of the 2026 Annual General Meeting
27th May 20267:00 amRNSTrading Update
12th May 20267:00 amRNSInvestor Presentation via Investor Meet Company
11th May 20267:00 amRNSNotification of Transactions of Directors/PDMRs
7th May 20267:00 amRNSIssue of Equity
30th Apr 20261:00 pmRNSFinal Dividend Payment Date
27th Apr 20267:00 amRNS2025 Annual Report and Notice of the 2026 AGM
15th Apr 20269:24 amRNSNotification of Transactions of Directors/PDMRs
31st Mar 20266:06 pmRNSHolding(s) in Company
25th Mar 20269:35 amRNSNotification Of Transactions Of Directors/PDMRs
17th Mar 20267:00 amRNSPreliminary Results
17th Mar 20267:00 amRNSPreliminary Results
16th Mar 20261:24 pmRNSNotification Of Transactions Of Directors/PDMRs
16th Mar 20261:24 pmRNSNotification Of Transactions Of Directors/PDMRs
11th Mar 20267:00 amRNSPreliminary results presentation
11th Mar 20267:00 amRNSPreliminary results presentation
13th Feb 20267:00 amRNSNotification Of Transactions Of Directors/PDMRs
27th Jan 20267:00 amRNSChange of Registered Office Address
22nd Jan 20267:00 amRNSTrading Update
15th Jan 20269:57 amRNSNotification Of Transactions Of Directors/PDMRs
15th Dec 20257:00 amRNSNotification Of Transactions Of Directors/PDMRs
18th Nov 202512:39 pmRNSAcquisition of Overseas Konstellation Company S.A.
12th Nov 20254:12 pmRNSNotification Of Transactions Of Directors/PDMRs
4th Nov 20257:00 amRNSTrading Update
24th Oct 20257:00 amRNSNon-Executive Directorate Changes
14th Oct 20252:54 pmRNSNotification Of Transactions Of Directors/PDMRs
9th Oct 20257:00 amRNSNotification Of Transactions Of Directors/PDMRs
30th Sep 20254:25 pmRNSNOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs
22nd Sep 20252:33 pmRNSGroup CFO succession
12th Sep 20255:11 pmRNSNotification Of Transactions Of Directors/PDMR
28th Aug 20257:00 amRNS-RInnovation Initiatives and Executive Appointment
19th Aug 20252:16 pmRNSHolding(s) in Company
14th Aug 20256:19 pmRNSHolding(s) in Company
12th Aug 20252:57 pmRNSNotification Of Transactions Of Directors/PDMR
8th Aug 20257:00 amRNSHolding(s) in Company
7th Aug 202512:14 pmRNSHolding(s) in Company
5th Aug 20257:01 amRNSJoint Venture Agreement and Executive Appointment
5th Aug 20257:00 amRNSInterim Results
29th Jul 202511:01 amRNSInvestor Presentation via Investor Meet Company
14th Jul 20252:51 pmRNSNotification Of Transactions Of Directors/PDMRs
12th Jun 20252:41 pmRNSNotification of Transactions of Directors/PDMRs
10th Jun 20254:13 pmRNSNotification Of Transactions Of Directors/PDMRs
22nd May 202512:30 pmRNSResult of the 2025 Annual General Meeting
22nd May 20257:00 amRNSTrading Update
13th May 202512:05 pmRNSNotification Of Transactions Of Directors/PDMRs
1st May 20257:00 amRNSNotification Of Transactions Of Directors/PDMRs
30th Apr 20257:00 amRNSGroup CFO succession
24th Apr 20257:00 amRNSNotification Of Transactions Of Directors/PDMRs

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.